Open Your FREE Demat Account Now!

N/A
indicator

Nifty50 Shariah

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty50 Shariah Performance

Low

₹3,897.00

High

₹3,959.60

52 Week Range

Low

₹3,857.20

High

₹4,982.45

Previous Close ₹3,929.95
Day's Range ₹3,897.00 - ₹3,959.60
Open ₹3,946.40
52 Week Range ₹3,857.20 - ₹4,982.45
Volume 6,34,60,147

Nifty50 Shariah Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1311.30 Arrow 10.30 (0.79%) Healthcare
Dr. Reddy's Laboratories Ltd. 1229.40 Arrow 32.40 (2.71%) Healthcare
Infosys Ltd. 1020.00 Arrow -3.40 (-0.33%) IT
Trent Ltd. 2913.00 Arrow -5.20 (-0.18%) Retailing
Oil & Natural Gas Corporation Ltd. 220.00 Arrow -1.27 (-0.57%) Crude Oil
Hindalco Industries Ltd. 882.50 Arrow -17.85 (-1.98%) Non - Ferrous Metals
Tata Motors Passenger Vehicles Ltd. 284.45 Arrow 4.55 (1.63%) Automobile & Ancillaries
Hindustan Unilever Ltd. 1820.70 Arrow -36.00 (-1.94%) FMCG
Nestle India Ltd. 1324.70 Arrow -8.30 (-0.62%) FMCG
Tata Consumer Products Ltd. 958.80 Arrow 3.80 (0.40%) Agri

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 22363.35 26373.20 22179.90
Nifty IT 28349.6 40301.40 25699.10
Nifty Next 50 68351.7 75000.40 59896.10
NIFTY50 USD Index 8097.4 10443.40 7839.85
Nifty Bank 54918.0 61764.85 49954.85
NIFTY Midcap 100 58834.55 64450.90 52032.85
Nifty 500 21822.75 24144.20 20385.65
Nifty Midcap 50 16827.65 18500.95 14804.55
Nifty 100 23426.15 26975.15 22720.45
Nifty FMCG 44113.4 57445.20 43442.30

Latest News

Oct
10
2026
EQUITY Posted on Oct 10th 2026

Max Healthcare Institute informs about credit rating

Max Healthcare Institute has informed about credit rating. CARE Ratings has upgraded the credit rating for Crosslay Remedies (formerly ‘Jaypee Healthcare Limited’) a wholly-owned material subsidiary of the Company.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
9
2026
EQUITY Posted on Oct 9th 2026

Infosys informs about newspaper advertisement

Infosys has informed that it attached, copies of the newspaper advertisement pertaining to loss of Share Certificates that are published in English and Kannada newspapers. This will also be hosted on the company’s website at www.infosys.com.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
9
2026
EQUITY Posted on Oct 9th 2026

Tata Consultancy Services informs about statement

In response to announcement by the US Government on the Permanent Labor Certification Program, Tata Consultancy Services has informed about a statement of the Company: ‘We have noted the announcement by the US Government on the Permanent Labor Certification Program (PERM) and TCS will comply with any directive from the Department of Labor. Our workforce strategy in the US is anchored in hiring local talent, supported by a robust campus recruitment model. We have built a significant local workforce across 31 offices and delivery centers throughout the country. As we had announced earlier, we intend to hire an additional 15,000 people in the US over the next five years, to further augment our local workforce. Our PERM applications were in single digits in the last two years and hence we do not expect the suspension of the program to impact our workforce strategy and customer engagements.’
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
1
2026
EQUITY Posted on Oct 1st 2026

UltraTech Cement informs about details of earnings call

UltraTech Cement has informed that, an Earnings Call on the financial results of the Company and its subsidiaries for the quarter ended 30th September, 2026 will be held on Monday, 19th October, 2026 at 4:00 pm (IST). Details relating to the said call are attached. This will also be available on the Company's website www.ultratechcement.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
28
2026
EQUITY Posted on Sep 28th 2026

Sun Pharmaceutical Industries informs about press release

Sun Pharmaceutical Industries has informed that it enclosed copy of the press release titled ‘LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a PCSK9 Inhibitor, Ex-US and China; Lyrokaul (lerodalcibep) Approved in the EU’ which shall be released after this intimation.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of SHARIAHNIF index?

The previous close of SHARIAHNIF index is ₹3907.35 as of 2026-10-12.

The total volume of SHARIAHNIF index is 63460147.00 as of 2026-10-12.

The percentage change in value of SHARIAHNIF index is -0.57% as of 2026-10-12.

The absolute increase in SHARIAHNIF index value since the previous trading day is ₹-22.6 as of 2026-10-12.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore